A detailed history of Jpmorgan Chase & CO transactions in Quanterix Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 217,957 shares of QTRX stock, worth $2.63 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
217,957
Previous 170,084 28.15%
Holding current value
$2.63 Million
Previous $2.25 Million 25.65%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$10.92 - $16.36 $522,773 - $783,202
47,873 Added 28.15%
217,957 $2.82 Million
Q2 2024

Aug 12, 2024

BUY
$12.26 - $23.78 $941,825 - $1.83 Million
76,821 Added 82.37%
170,084 $2.25 Million
Q1 2024

May 10, 2024

BUY
$21.9 - $28.28 $69,861 - $90,213
3,190 Added 3.54%
93,263 $2.2 Million
Q4 2023

Feb 12, 2024

SELL
$19.54 - $28.66 $19 - $28
-1 Reduced -0.0%
90,073 $2.46 Million
Q3 2023

Nov 14, 2023

SELL
$21.15 - $27.96 $182,926 - $241,826
-8,649 Reduced 8.76%
90,074 $2.44 Million
Q2 2023

Aug 11, 2023

SELL
$11.16 - $23.65 $385,209 - $816,327
-34,517 Reduced 25.91%
98,723 $2.23 Million
Q1 2023

May 18, 2023

BUY
$10.12 - $14.91 $263,160 - $387,719
26,004 Added 24.25%
133,240 $1.5 Million
Q1 2023

May 11, 2023

SELL
$10.12 - $14.91 $352,327 - $519,091
-34,815 Reduced 24.51%
107,236 $1.21 Million
Q4 2022

Feb 13, 2023

BUY
$8.75 - $14.02 $466,410 - $747,322
53,304 Added 60.06%
142,051 $1.97 Million
Q3 2022

Nov 14, 2022

SELL
$7.46 - $19.28 $13,853 - $35,802
-1,857 Reduced 2.05%
88,747 $978,000
Q2 2022

Aug 11, 2022

BUY
$15.06 - $30.65 $231,562 - $471,274
15,376 Added 20.44%
90,604 $1.47 Million
Q1 2022

May 11, 2022

BUY
$23.26 - $42.41 $21,073 - $38,423
906 Added 1.22%
75,228 $2.2 Million
Q4 2021

Feb 10, 2022

SELL
$37.54 - $57.51 $47,675 - $73,037
-1,270 Reduced 1.68%
74,322 $3.15 Million
Q3 2021

Nov 12, 2021

BUY
$45.91 - $59.67 $3.47 Million - $4.51 Million
75,592 New
75,592 $3.76 Million

Others Institutions Holding QTRX

About Quanterix Corp


  • Ticker QTRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 36,987,600
  • Market Cap $446M
  • Description
  • Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detecti...
More about QTRX
Track This Portfolio

Track Jpmorgan Chase & CO Portfolio

Follow Jpmorgan Chase & CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.